{
    "2019-11-08": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial",
                "features": {
                    "keywords": [
                        "drug",
                        "fails",
                        "endpoints",
                        "gastric",
                        "cancer",
                        "trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pfizer",
                        "Phase III",
                        "JAVELIN",
                        "Gastric",
                        "Trial"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial",
                "features": {
                    "keywords": [
                        "EMD Serono",
                        "Pfizer",
                        "Phase III",
                        "JAVELIN",
                        "Gastric",
                        "Trial"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}